Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of obstructive jaundice on etomidate pharmacokinetics
ChiCTR-IPR-15007574Phase 4Recruiting
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of etomidate in obstructive jaundice (2 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Plasma drug concentration. Started Dec 2015; status: recruiting.
02
Drugs
etomidate
03
Conditions
obstructive jaundice
Beyond the preview
Go deeper on ChiCTR-IPR-15007574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007574.